Cost analysis in a cohort of rheumatoid arthritis patients managed in rheumatology units in Spain;Análisis de costes en una cohorte de enfermos con artritis reumatoide atendidos en área especializada de reumatología en España

Reumatologia Clinica

Volumn 1, Issue 4, 2005, Pages 193-199

  Ruiz Montesinos, M D ^a   Hernandez Cruz B ^a   Ariza Ariza, R ^a   Carmona, L ^b   Ballina, J ^c   Navarro Sarabia, F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b UNIDAD DE INVESTIGACIÓN   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Costs; Rheumatoid arthritis; Rheumatology

Indexed keywords

EID: 33746402539     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(05)72744-3     Document Type: Article

References (23)

1. Ludbeck D.P. The economic impact of arthritis. Arthritis Care Res 8 (1995) 304-310
2. Cooper N.J. Economic burden of rheumatoid arthritis a systemic review. Rheumatology (Oxford) 39 (2000) 28-33
3. Carmona L. Epidemiología de la artritis reumatoide. Rev Esp Reumatol 29 (2002) 86-89
4. Yelin E., Trupin L., Wong B., and Rush S. The impact of functional status and change in functional status on mortality over years among persons with rheumatoid arthritis. J Rheumatol 29 (2002) 1851-1857
5. Yelin E. Musculoskeletal conditions and employment. Arthitis Care Res 8 (1995) 311-317
6. Macarrón M.P., and Jover J.A. Impacto socioeconómico y costes. In: Laffon A., and Gómez-Reino J.J. (Eds). Artritis reumatoide. Sociedad Española de Reumatología (2003), Drug Farma 57-64
7. Palferman T.G. Principles of rheumatoid arthritis control. J Rheumatol 30 Suppl 67 (2003) 10-13
8. Lajas C., Abasolo L., Boutayeb B., Hernández-García C., Carmona L., Vargas E., et al. Costs and predictors of costs in rheumatoid arthritis: A Prevalence-Based Study. Arthitis Rheum 49 (2003) 64-70
9. Lubeck D.P. A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service setting. Pharmacoeconomics 19 (2001) 811-818
10. Ruiz-Montesinos M.D., Hernández-Cruz B., Ariza-Ariza R., Carmona L., Ballina J., Navarro-Sarabia F., and Grupo de Estudio de Costes y Calidad de Vida en Artritis Reumatoide de la Sociedad Española de Reumatología. Utilización de recursos en una cohorte de enfermos con artritis reumatoide atendidos en área especializada de reumatología en España. Reumatol Clin 1 (2005) 193-199
11. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
12. Villaverde V., Hernández-García C., and Carmona L. Artritis Reumatoide. Estudio EPISER. Prevalencia e impacto de las enfermedades reumáticas en la población adulta española (2001), Sociedad Española de Reumatología, Madrid p. 53-60
13. Yelin E. The costs of rheumatoid arthritis: absolute incremental, and marginal estimates. J Rheumatol Suppl 44 (1996) 47-51
14. Gabriel S.E., Crowson C.S., Campion M.E., and O'Fallon W.H. Direct medical costs unique to people with arthritis. J Rheumatol 24 (1997) 719-725
15. Gabriel S.E., Crowson C.S., Campion M.E., and O'Fallon W.H. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritis controls. J Rheumatol 24 (1997) 43-48
16. Ludbeck D.P., Spitz P.W., Wolfe F., Mitchell D.M., and Roth S.H. A multicenter study of annual health service; utilization and cost in rheumatoid arthritis. Arthritis Rheum 29 (1986) 488-493
17. Yelin E. An assessment of the annual long-term directs costs of rheumatoid arthritis: the impact of poor function and functional decline. Arthritis Rheum 42 (1999) 1209-1218
18. Clarke A.E., Zowall H., Levinton C., Assima K.H., Sibley J.T., Haga M., et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. J Rheumatol 24 (1997) 1051-1060
19. Lanes S.F., Lanza L.L., Radeusky P.W., Jood R.A., Mecuan R.F., Walker A.M., et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 40 (1997) 1475-1481
20. Michaud K., Messer J., Choi H.K., and Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis. Arthritis Rheum 48 (2003) 2750-2762
21. Ruof J., Hulseman J.L., Mittendorf T., Handelmam S., Von der Shulembug J.M., Zeidler H., et al. Costs of rheumatoid arthritis in Germay: a microcoting approach based on healtheare payer's date sources. Ann Rheum Dis 62 (2003) 544-549
22. Tornero J., Piqueras J.A., Carballo L.F., and Vidal J. Epidemiología de la discapacidad laboral debida a las enfermedades reumáticas. Rev Esp Reumatol 29 (2002) 373-384
23. Gabriel S.E., Crowson C.S., and O'Fallon W.M. Comorbility in arthritis. J Rheumatol 26 (1999) 2475-2479